Cargando…

Establishment and characterization of a novel ovarian high-grade serous carcinoma cell line—IPO43

BACKGROUND: Epithelial ovarian cancer (EOC) is an aggressive and lethal malignancy and novel EOC cell lines with detailed characterization are needed, to provide researchers with diverse helpful resources to study EOC biological processes and cancer experimental therapies. METHODS: The IPO43 cell li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Fernanda, Coelho, Filipa, Peixoto, Ana, Pinto, Pedro, Martins, Carmo, Frombach, Ann-Sophie, Santo, Vítor E., Brito, Catarina, Guimarães, António, Félix, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063187/ https://www.ncbi.nlm.nih.gov/pubmed/35501869 http://dx.doi.org/10.1186/s12935-022-02600-3

Ejemplares similares

High-profit IPO strategies: finding breakout IPOs for investors and traders
por: Taulli, Tom, et al.
Publicado: (2013)

Corporate governance in IPO firms
por: Lehmann, Erik E, et al.
Publicado: (2020)

Latent class analysis of IPOs in the Nordics
por: Bask, Mikael, et al.
Publicado: (2021)

Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
por: Nunes, Sofia C., et al.
Publicado: (2018)

Correction: Latent class analysis of IPOs in the Nordics
Publicado: (2023)

Low-grade serous epithelial ovarian cancer: a comprehensive review and update for radiologists
por: Amante, Sofia, et al.
Publicado: (2021)

Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8
por: Tudrej, Patrycja, et al.
Publicado: (2018)

Regulation A+ and Other Alternatives to a Traditional IPO
por: Feldman, David
Publicado: (2018)

IPO: a tool for automated optimization of XCMS parameters
por: Libiseller, Gunnar, et al.
Publicado: (2015)

Unicorns’ growth and financial flexibility before and after the IPO
por: Zhou, Man, et al.
Publicado: (2023)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids
por: Senkowski, Wojciech, et al.
Publicado: (2023)

Establishment of cancer cell line originating from a patient with high-grade serous ovarian carcinoma
por: Linh, Nguyen Thuy, et al.
Publicado: (2023)

COVID-19: Fear of pandemic and short-term IPO performance
por: Mazumder, Sharif, et al.
Publicado: (2021)

Nuclear Transporter IPO13 Is Central to Efficient Neuronal Differentiation
por: Gajewska, Katarzyna A., et al.
Publicado: (2022)

Competitive threat and strategic disclosure during the IPO quiet period
por: Qiu, Yetaotao, et al.
Publicado: (2022)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis
por: Drumond-Bock, Ana Luiza, et al.
Publicado: (2021)

Comparable Stocks, Boundedly Rational Stock Markets and IPO Entry Rates
por: Chok, Jay, et al.
Publicado: (2013)

Mutation of IPO13 causes recessive ocular coloboma, microphthalmia, and cataract
por: Huang, Xiu-Feng, et al.
Publicado: (2018)

High-grade serous ovarian carcinoma organoids as models of chromosomal instability
por: Vias, Maria, et al.
Publicado: (2023)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
por: Ribeiro e Ribeiro, Renan, et al.
Publicado: (2021)

Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status
por: Li, Yongmei, et al.
Publicado: (2022)

Monocytes as Endothelial Progenitor Cells (EPCs), Another Brick in the Wall to Disentangle Tumor Angiogenesis
por: Lopes-Coelho, Filipa, et al.
Publicado: (2020)

NMDAR signaling facilitates the IPO5-mediated nuclear import of CPEB3
por: Chao, Hsu-Wen, et al.
Publicado: (2012)

Aftermarket Performance of Health Care and Biopharmaceutical IPOs: Evidence From ASEAN Countries
por: Komenkul, Kulabutr, et al.
Publicado: (2017)

Epstein-Barr Virus Limits the Accumulation of IPO7, an Essential Gene Product
por: Yang, Ya-Chun, et al.
Publicado: (2021)

Translation and cultural adaptation of IPOS (integrated palliative care outcome scale) in Estonia
por: Laissaar, Merli, et al.
Publicado: (2021)

IPO7 promotes pancreatic cancer progression via regulating ERBB pathway
por: Li, Ming, et al.
Publicado: (2022)

Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma
por: Norris, Eric J, et al.
Publicado: (2019)

Patient-derived ovarian cancer explants: preserved viability and histopathological features in long-term agitation-based cultures
por: Abreu, Sofia, et al.
Publicado: (2020)

The peritoneal tumour microenvironment of high-grade serous ovarian cancer
por: Leinster, D Andrew, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bcgpqmpuv1u62o0ah36cl4q5ha